Uterine cancer affects 28 in 100,000 women annually. Learn the 5 critical warning signs that could save your life and why ...

It was from the father of a woman with uterine cancer desperately pitching me a story about how research into/treatment of gynecological cancers is underfunded — resulting in appalling survival ...

The FDA has cleared GSK's PD-1 inhibitor Jemperli as a treatment for all adult patients with primary advanced or recurrent endometrial cancer, a key part of the company's growth ambitions for the ...